Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-mwx4w Total loading time: 0 Render date: 2024-07-02T07:11:17.817Z Has data issue: false hasContentIssue false

8 - Epidemiology, Etiology, and Pathogenesis of Malignant Mesothelioma

Published online by Cambridge University Press:  16 March 2018

By
Alberto M. Marchevsky
Edited by
Alberto M. Marchevsky ,
Aliya N. Husain  and
Françoise Galateau-Sallé
Alberto M. Marchevsky
Affiliation:
Cedars Sinai Medical Center, Los Angeles
Aliya N. Husain
Affiliation:
University of Chicago
Françoise Galateau-Sallé
Affiliation:
MESOPATH National Reference Center & Cancer Center Leon Berard
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Practical Pathology of Serous Membranes , pp. 91 - 97
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Beebe-Dimmer, JL, Fryzek, JP, Yee, CL, Dalvi, TB, Garabrant, DH, Schwartz, AG, et al. Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)–Medicare investigation of treatment patterns and overall survival. Clin Epidemiol. 2016;8:743–50.CrossRefGoogle ScholarPubMed
Magnani, C, Bianchi, C, Chellini, E, Consonni, D, Fubini, B, Gennaro, V, et al. III Italian Consensus Conference on Malignant Mesothelioma of the Pleura. Epidemiology, Public Health and Occupational Medicine related issues. Med Lav. 2015;106:325–32.Google Scholar
Marinaccio, A, Binazzi, A, Bonafede, M, Corfiati, M, Di Marzio, D, Scarselli, A, et al. Malignant mesothelioma due to non-occupational asbestos exposure from the Italian national surveillance system (ReNaM): epidemiology and public health issues. Occup Environ Med. 2015;72:648–55.CrossRefGoogle ScholarPubMed
Craighead, JE. Epidemiology of mesothelioma and historical background. Recent Results Cancer Res. 2011;189:13–25.Google Scholar
Roggli, VL, Sharma, A, Butnor, KJ, Sporn, T, Vollmer, RT. Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases. Ultrastruct Pathol. 2002;26:55–65.CrossRefGoogle ScholarPubMed
Geltner, C, Errhalt, P, Baumgartner, B, Ambrosch, G, Machan, B, Eckmayr, J, et al. Management of malignant pleural mesothelioma – part 1: epidemiology, diagnosis, and staging: Consensus of the Austrian Mesothelioma Interest Group (AMIG). Wien Klin Wochenschr. 2016;128:611–17.CrossRefGoogle ScholarPubMed
Taioli, E, Wolf, AS, Camacho-Rivera, M, Kaufman, A, Lee, DS, Nicastri, D, et al. Determinants of survival in malignant pleural mesothelioma: a Surveillance, Epidemiology, and End Results (SEER) study of 14,228 patients. PLoS ONE. 2015;10:e0145039.Google Scholar
Meyerhoff, RR, Yang, CF, Speicher, PJ, Gulack, BC, Hartwig, MG, D'Amico, TA, et al. Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database. J Surg Res. 2015;196:23–32.CrossRefGoogle ScholarPubMed
Budroni, M, Cossu, A, Paliogiannis, P, Palmieri, G, Attene, F, Cesaraccio, R, et al. Epidemiology of malignant pleural mesothelioma in the province of Sassari (Sardinia, Italy). A population-based report. Ann Ital Chir. 2014;85:244–48.Google Scholar
Akl, Y, Kaddah, S, Abdelhafeez, A, Salah, R, Lotayef, M. Epidemiology of mesothelioma in Egypt. A ten-year (1998–2007) multicentre study. Arch Med Sci. 2010;6:926–31.CrossRefGoogle ScholarPubMed
McDonald, JC. Epidemiology of malignant mesothelioma–an outline. Ann Occup Hyg. 2010;54:851–57.Google ScholarPubMed
Flores, RM, Riedel, E, Donington, JS, Alago, W, Ihekweazu, U, Krug, L, et al. Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population. J Thorac Oncol. 2010;5;1649–54.CrossRefGoogle Scholar
Ugolini, D, Neri, M, Canessa, PA, Casilli, C, Catrambone, G, Ivaldi, GP, et al. The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases. Cancer Epidemiol Biomarkers Prev. 2008;17:3013–19.Google Scholar
Yang, H, Testa, JR, Carbone, M. Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Curr Treat Options Oncol. 2008;9:147–57.CrossRefGoogle ScholarPubMed
Chapman, A, Mulrennan, S, Ladd, B, Muers, MF. Population based epidemiology and prognosis of mesothelioma in Leeds, UK. Thorax. 2008;63;435–39.CrossRefGoogle ScholarPubMed
Metintas, M, Metintas, S, Ak, G, Erginel, S, Alatas, F, Kurt, E, et al. Epidemiology of pleural mesothelioma in a population with non-occupational asbestos exposure. Respirology. 2008;13:117–21.Google Scholar
Mak, V, Davies, E, Putcha, V, Choodari-Oskooei, B, Moller, H. The epidemiology and treatment of mesothelioma in South East England 1985–2002. Thorax. 2008;63:160–66.Google Scholar
Larson, T, Melnikova, N, Davis, SI, Jamison, P. Incidence and descriptive epidemiology of mesothelioma in the United States, 1999–2002. Int J Occup Environ Health. 2007;13:398–403.Google Scholar
Boffetta, P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007;18:985–90.CrossRefGoogle ScholarPubMed
Yarborough, CM. Chrysotile as a cause of mesothelioma: an assessment based on epidemiology. Crit Rev Toxicol. 2006;36:165–87.CrossRefGoogle ScholarPubMed
Bertazzi, PA. Descriptive epidemiology of malignant mesothelioma. Med Lav. 2005;96:287–303.Google Scholar
Bolognesi, C, Martini, F, Tognon, M, Filiberti, R, Neri, M, Perrone, E, et al. A molecular epidemiology case control study on pleural malignant mesothelioma. Cancer Epidemiol Biomarkers Prev. 2005;14:1741–46.CrossRefGoogle ScholarPubMed
Abratt, RP, White, NW, Vorobiof, DA. Epidemiology of mesothelioma – a South African perspective. Lung Cancer. 2005;49(Suppl 1):S13–15.CrossRefGoogle ScholarPubMed
Zellos, L, Christiani, DC. Epidemiology, biologic behavior, and natural history of mesothelioma. Thorac Surg Clin. 2004;14:469–77, viii.CrossRefGoogle ScholarPubMed
Lange, JH. Re: “Mesothelioma trends in the United States: an update based on surveillance, epidemiology, and end results program data for 1973 through 2003”. Am J Epidemiol. 2004;160:823.CrossRefGoogle Scholar
Filiberti, R, Montanaro, F. Epidemiology of pleural mesothelioma in Italy. Lung Cancer. 2004;45(Suppl 1):S25–27.Google Scholar
Musk, AW, de Klerk, NH. Epidemiology of malignant mesothelioma in Australia. Lung Cancer. 2004;45(Suppl 1):S21–23.CrossRefGoogle ScholarPubMed
Price, B, Ware, A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol. 2004;159:107–12.CrossRefGoogle ScholarPubMed
Puntoni, R. Molecular epidemiology of mesothelioma. Pathologica. 2003;95:291–97.Google Scholar
Puntoni, R, Filiberti, R, Cerrano, PG, Neri, M, Andreatta, R, Bonassi, S. Implementation of a molecular epidemiology approach to human pleural malignant mesothelioma. Mutat Res. 2003;544:385–96.Google Scholar
Britton, M. The epidemiology of mesothelioma. Semin Oncol. 2002;29;18–25.CrossRefGoogle ScholarPubMed
McDonald, AD, Case, BW, Churg, A, Dufresne, A, Gibbs, GW, Sebastien, P, et al. Mesothelioma in Quebec chrysotile miners and millers: epidemiology and aetiology. Ann Occup Hyg. 1997;41:707–19.CrossRefGoogle ScholarPubMed
McLean, AN, Patel, KR. Clinical features and epidemiology of malignant pleural mesothelioma in west Glasgow 1987–1992. Scott Med J. 1997;42:37–39.CrossRefGoogle ScholarPubMed
McDonald, JC, McDonald, AD. The epidemiology of mesothelioma in historical context. Eur Respir J. 1996;9:1932–42.CrossRefGoogle ScholarPubMed
Ross, D, McDonald, JC. Occupational and geographical factors in the epidemiology of malignant mesothelioma. Monaldi Arch Chest Dis. 1995;50:459–63.Google ScholarPubMed
Antman, KH. Natural history and epidemiology of malignant mesothelioma. Chest. 1993;103:373S–76S.CrossRefGoogle ScholarPubMed
Walz, R, Koch, HK. Malignant pleural mesothelioma: some aspects of epidemiology, differential diagnosis and prognosis. Histological and immunohistochemical evaluation and follow-up of mesotheliomas diagnosed from 1964 to January 1985. Pathol Res Pract. 1990;186:124–34.Google ScholarPubMed
Craighead, JE. The epidemiology and pathogenesis of malignant mesothelioma. Chest. 1989;96:92S–93S.CrossRefGoogle ScholarPubMed
Huncharek, M. The epidemiology of pleural mesothelioma: current concepts and controversies. Cancer Invest. 1989;7:93–99.CrossRefGoogle ScholarPubMed
Demopoulos, RI, Kahn, MA, Feiner, HD. Epidemiology of cystic mesothelioma. Int J Gynecol Pathol. 1986;5:379–81.Google ScholarPubMed
Armstrong, BK, Musk, AW, Baker, JE, Hunt, JM, Newall, CC, Henzell, HR, et al. Epidemiology of malignant mesothelioma in Western Australia. Med J Aust. 1984;141:86–88.CrossRefGoogle ScholarPubMed
Browne, K. The epidemiology of mesothelioma. J Soc Occup Med. 1983;33:190–94.CrossRefGoogle ScholarPubMed
McDonald, JC, McDonald, AD. Epidemiology of mesothelioma from estimated incidence. Prev Med. 1977;6:426–42.Google Scholar
Lemesch, C, Steinitz, R, Wassermann, M. Epidemiology of mesothelioma in Israel. Environ Res. 1976;12:255–61.Google Scholar
Rubino, GF, Scansetti, G, Donna, A, Palestro, G. Epidemiology of pleural mesothelioma in North-western Italy (Piedmont). Br J Ind Med. 1972;29;436–42.Google Scholar
Stumphius, J. Epidemiology of mesothelioma on Walcheren Island. Br J Ind Med. 1971;28:59–66.Google ScholarPubMed
Stanton, MF, Wrench, C. Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst. 1972;48:797–821.Google ScholarPubMed
Bernstein, DM, Chevalier, J, Smith, P. Comparison of Calidria chrysotile asbestos to pure tremolite: final results of the inhalation biopersistence and histopathology examination following short-term exposure. Inhal Toxicol. 2005;17:427–49.Google ScholarPubMed
Bernstein, DM, Chevalier, J, Smith, P. Comparison of Calidria chrysotile asbestos to pure tremolite: inhalation biopersistence and histopathology following short-term exposure. Inhal Toxicol. 2003;15:1387–419.Google ScholarPubMed
Berry, G. Models for mesothelioma incidence following exposure to fibers in terms of timing and duration of exposure and the biopersistence of the fibers. Inhal Toxicol. 1999;11:111–30.CrossRefGoogle ScholarPubMed
Kane, AB. Animal models of malignant mesothelioma. Inhal Toxicol. 2006;18:1001–04.Google Scholar
Miller, BG, Searl, A, Davis, JM, Donaldson, K, Cullen, RT, Bolton, RE, et al. Influence of fibre length, dissolution and biopersistence on the production of mesothelioma in the rat peritoneal cavity. Ann Occup Hyg. 1999;43:155–66.CrossRefGoogle ScholarPubMed
Whitaker, D, Shilkin, KB, Walters, MN. Cytologic and tissue culture characteristics of asbestos-induced mesothelioma in rats. Acta Cytol. 1984;28:185–89.Google ScholarPubMed
Minami, D, Takigawa, N, Kato, Y, Kudo, K, Isozaki, H, Hashida, S, et al. Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model. Cancer Sci. 2015;106:1296–302.CrossRefGoogle Scholar
Cunniff, B, Newick, K, Nelson, KJ, Wozniak, AN, Beuschel, S, Leavitt, B, et al. Disabling mitochondrial peroxide metabolism via combinatorial targeting of peroxiredoxin 3 as an effective therapeutic approach for malignant mesothelioma. PLoS ONE. 2015;10:e0127310.CrossRefGoogle ScholarPubMed
Blackshear, PE, Pandiri, AR, Nagai, H, Bhusari, S, Hong, HH, Ton, TV, et al. Gene expression of mesothelioma in vinylidene chloride-exposed F344/N rats reveal immune dysfunction, tissue damage, and inflammation pathways. Toxicol Pathol. 2015;43:171–85.Google Scholar
Zhong, J, Lardinois, D, Szilard, J, Tamm, M, Roth, M. Rat mesothelioma cell proliferation requires p38delta mitogen activated protein kinase and C/EBP-alpha. Lung Cancer. 2011;73:166–70.Google Scholar
Mark, EJ, Kradin, RL. Pathological recognition of diffuse malignant mesothelioma of the pleura: the significance of the historical perspective as regards this signal tumor. Semin Diagn Pathol. 2006;23:25–34.CrossRefGoogle ScholarPubMed
Smith, AH, Wright, CC. Chrysotile asbestos is the main cause of pleural mesothelioma. Am J Ind Med. 1996;30:252–66.3.0.CO;2-0>CrossRefGoogle ScholarPubMed
Teschke, K. Thinking about occupation–response and exposure–response relationships: vehicle mechanics, chrysotile, and mesothelioma. Ann Occup Hyg. 2016;60:528–30.CrossRefGoogle ScholarPubMed
Garabrant, DH, Alexander, DD, Miller, PE, Fryzek, JP, Boffetta, P, Teta, MJ, et al. Mesothelioma among motor vehicle mechanics: an updated review and meta-analysis. Ann Occup Hyg. 2016;60:8–26.CrossRefGoogle ScholarPubMed
Hessel, PA, Teta, MJ, Goodman, M, Lau, E. Mesothelioma among brake mechanics: an expanded analysis of a case-control study. Risk Anal. 2004;24:547–52.Google Scholar
Goodman, M, Teta, MJ, Hessel, PA, Garabrant, DH, Craven, VA, Scrafford, CG, et al. Mesothelioma and lung cancer among motor vehicle mechanics: a meta-analysis. Ann Occup Hyg. 2004;48:309–26.Google ScholarPubMed
Robinson, CF, Petersen, M, Sieber, WK, Palu, S, Halperin, WE. Mortality of Carpenters’ Union members employed in the US construction or wood products industries, 1987–1990. Am J Ind Med. 1996;30:674–94.3.0.CO;2-R>CrossRefGoogle ScholarPubMed
Case, BW, Abraham, JL, Meeker, G, Pooley, FD, Pinkerton, KE. Applying definitions of “asbestos” to environmental and “low-dose” exposure levels and health effects, particularly malignant mesothelioma. J Toxicol Environ Health B Crit Rev. 2011;14:3–39.CrossRefGoogle ScholarPubMed
Welch, LS. Asbestos exposure causes mesothelioma, but not this asbestos exposure: an amicus brief to the Michigan Supreme Court. Int J Occup Environ Health. 2007;13:318–27.CrossRefGoogle ScholarPubMed
Marchevsky, AM, Walts, AE, Wick, MR. Evidence-based pathology in its second decade: toward probabilistic cognitive computing. Hum Pathol. 2017;61:1–8.Google Scholar
Marchevsky, AM, Wick, MR. Evidence-based guidelines for the utilization of immunostains in diagnostic pathology: pulmonary adenocarcinoma versus mesothelioma. Appl Immunohistochem Mol Morphol. 2007;15:140–44.CrossRefGoogle ScholarPubMed
Marchevsky, AM. Evidence-based medicine in pathology: an introduction. Semin Diagn Pathol. 2005;22:105–15.CrossRefGoogle ScholarPubMed
Marchevsky, AM, Wick, MR. Current controversies regarding the role of asbestos exposure in the causation of malignant mesothelioma: the need for an evidence-based approach to develop medicolegal guidelines. Ann Diagn Pathol. 2003;7:321–32.Google Scholar
Malignant mesothelioma mortality. United States, 1999–2015. www.cdc.gov.mmwr/volumes/66/wr/mm608a3.htm.Google Scholar
Leigh, J, Driscoll, T. Malignant mesothelioma in Australia, 1945–2002. Int J Occup Environ Health. 2003;9:206–17.Google Scholar
Hassan, R, Alexander, R, Antman, K, Boffetta, P, Churg, A, Coit, D, et al. Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol. 2006;17:1615–19.Google Scholar
Wagner, JC, Sleggs, CA, Marchand, P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960;17:260–71.Google Scholar
Selikoff, IJ, Churg, J, Hammond, EC. Relation between exposure to asbestos and mesothelioma. N Engl J Med. 1965;272:560–65.CrossRefGoogle ScholarPubMed
Roggli, VL, Vollmer, RT, Butnor, KJ, Sporn, TA. Tremolite and mesothelioma. Ann Occup Hyg. 2002;46:447–53.Google Scholar
EPA summary of published measurements of asbestos levels in ambient air. www.epa.gov/sites/production/files/2013-08/documents/libbyasbestos_ambientairlitsearch5-20-2013.pdf.Google Scholar
Carbone, M, Kanodia, S, Chao, A, Miller, A, Wali, A, Weissman, D, et al. Consensus Report of the 2015 Weinman International Conference on Mesothelioma. J Thorac Oncol. 2016;11:1246–62.CrossRefGoogle ScholarPubMed
Carbone, M, Ly, BH, Dodson, RF, Pagano, I, Morris, PT, Dogan, UA, et al. Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol. 2012;227:44–58.Google Scholar
Hodgson, JT, Darnton, A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 2000;44:565–601.Google Scholar
Berman, DW, Crump, KS. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol. 2008;38(Suppl 1):49–73.Google Scholar
Berman, DW, Crump, KS. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol. 2008;38(Suppl 1):1–47.CrossRefGoogle ScholarPubMed
Hodgson, JT, Darnton, A. Mesothelioma risk from chrysotile. Occup Environ Med. 2010;67:432.CrossRefGoogle ScholarPubMed
Ferrante, D, Mirabelli, D, Tunesi, S, Terracini, B, Magnani, C. Pleural mesothelioma and occupational and non-occupational asbestos exposure: a case-control study with quantitative risk assessment. Occup Environ Med. 2016;73:147–53.Google ScholarPubMed
Marchevsky, AM, Harber, P, Crawford, L, Wick, MR. Mesothelioma in patients with nonoccupational asbestos exposure. An evidence-based approach to causation assessment. Ann Diagn Pathol. 2006;10:241–50.CrossRefGoogle ScholarPubMed
Bang, KM, Pinheiro, GA, Wood, JM, Syamlal, G. Malignant mesothelioma mortality in the United States, 1999–2001. Int J Occup Environ Health. 2006;12:9–15.CrossRefGoogle ScholarPubMed
Goldberg, M, Imbernon, E, Rolland, P, Gilg, Soit Ilg A, Saves, M, de Quillacq, A, et al. The French National Mesothelioma Surveillance Program. Occup Environ Med. 2006;63:390–95.CrossRefGoogle ScholarPubMed
Carbone, M, Baris, YI, Bertino, P, Brass, B, Comertpay, S, Dogan, AU, et al. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proc Natl Acad Sci U S A. 2011;108:13618–23.CrossRefGoogle ScholarPubMed
Tanrikulu, AC, Senyigit, A, Dagli, CE, Babayigit, C, Abakay, A. Environmental malignant pleural mesothelioma in Southeast Turkey. Saudi Med J. 2006;27:1605–07.Google Scholar
Senyigit, A, Dalgic, A, Kavak, O, Tanrikulu, AC. Determination of environmental exposure to asbestos (tremolite) and mesothelioma risks in the southeastern region of Turkey. Arch Environ Health. 2004;59:658–62.Google Scholar
Lilis, R. Fibrous zeolites and endemic mesothelioma in Cappadocia, Turkey. J Occup Med. 1981;23:548–50.Google Scholar
Baris, YI, Artvinli, M, Sahin, AA. Environmental mesothelioma in Turkey. Ann N Y Acad Sci. 1979;330:423–32.CrossRefGoogle ScholarPubMed
Teta, MJ, Lau, E, Sceurman, BK, Wagner, ME. Therapeutic radiation for lymphoma: risk of malignant mesothelioma. Cancer. 2007;109:1432–38.Google Scholar
Witherby, SM, Butnor, KJ, Grunberg, SM. Malignant mesothelioma following thoracic radiotherapy for lung cancer. Lung Cancer. 2007;57:410–13.Google Scholar
Cerrano, PG, Jasani, B, Filiberti, R, Neri, M, Merlo, F, De Flora, S, et al. Simian virus 40 and malignant mesothelioma (Review). Int J Oncol. 2003;22:187–94.Google ScholarPubMed
Carbone, M, Pass, HI, Rizzo, P, Marinetti, M, Di Muzio, M, Mew, DJ, et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene. 1994;9:1781–90.Google ScholarPubMed
Henzi, T, Blum, WV, Pfefferli, M, Kawecki, TJ, Salicio, V, Schwaller, B. SV40-induced expression of calretinin protects mesothelial cells from asbestos cytotoxicity and may be a key factor contributing to mesothelioma pathogenesis. Am J Pathol. 2009;174:2324–36.Google Scholar
Bianchi, C, Brollo, A, Ramani, L, Bianchi, T, Giarelli, L. Familial mesothelioma of the pleura–a report of 40 cases. Ind Health. 2004;42:235–39.Google Scholar
Musti, M, Cavone, D, Aalto, Y, Scattone, A, Serio, G, Knuutila, S. A cluster of familial malignant mesothelioma with del(9p) as the sole chromosomal anomaly. Cancer Genet Cytogenet. 2002;138:73–76.CrossRefGoogle ScholarPubMed
Ascoli, V, Mecucci, C, Knuutila, S. Genetic susceptibility and familial malignant mesothelioma. Lancet. 2001;357:1804.CrossRefGoogle ScholarPubMed
Ascoli, V, Aalto, Y, Carnovale-Scalzo, C, Nardi, F, Falzetti, D, Mecucci, C, et al. DNA copy number changes in familial malignant mesothelioma. Cancer Genet Cytogenet. 2001;127:80–82.Google Scholar
Kubo, T, Toyooka, S, Tsukuda, K, Sakaguchi, M, Fukazawa, T, Soh, J, et al. Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma. Clin Cancer Res. 2011;17:4965–74.CrossRefGoogle ScholarPubMed
Weiner, SJ, Neragi-Miandoab, S. Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors. J Cancer Res Clin Oncol. 2009;135:15–27.CrossRefGoogle ScholarPubMed
Carbone, M, Albelda, SM, Broaddus, VC, Flores, RM, Hillerdal, G, Jaurand, MC, et al. Eighth international mesothelioma interest group. Oncogene. 2007;26:6959–67.CrossRefGoogle ScholarPubMed
Boutin, C, Dumortier, P, Rey, F, Viallat, JR, De Vuyst, P. Black spots concentrate oncogenic asbestos fibers in the parietal pleura. Thoracoscopic and mineralogic study. Am J Respir Crit Care Med. 1996;153:444–49.Google Scholar
Suzuki, Y, Yuen, SR, Ashley, R. Short, thin asbestos fibers contribute to the development of human malignant mesothelioma: pathological evidence. Int J Hyg Environ Health. 2005;208:201–10.Google Scholar
Iigren, E. The fiber length of Coaling chrysotile: Enhanced clearance due to its short nature in aqueous solution with a brief critique on “short fiber toxicity”. Indoor Built Environ. 2008;17:5–26.CrossRefGoogle Scholar
Carbone, M, Gaudino, G, Yang, H. Recent insights emerging from malignant mesothelioma genome sequencing. J Thorac Oncol. 2015;10:409–11.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×